242 related articles for article (PubMed ID: 34750100)
21. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
[No Abstract] [Full Text] [Related]
22. Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.
Khojasteh H; Riazi-Esfahani H; Khalili Pour E; Faghihi H; Ghassemi F; Bazvand F; Mahmoudzadeh R; Salabati M; Mirghorbani M; Riazi Esfahani M
Int Ophthalmol; 2020 Mar; 40(3):571-581. PubMed ID: 31712927
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema.
Chatziralli I; Dimitriou E; Lambadiari V; Kazantzis D; Kapsis P; Theodossiadis G; Theodossiadis P; Sergentanis TN
Semin Ophthalmol; 2022 Jul; 37(5):668-675. PubMed ID: 35468026
[TBL] [Abstract][Full Text] [Related]
24. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
25. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy.
Borrelli E; Grosso D; Barresi C; Lari G; Sacconi R; Senni C; Querques L; Bandello F; Querques G
Am J Ophthalmol; 2022 Mar; 235():80-89. PubMed ID: 34509431
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study.
Granstam E; Rosenblad A; Modher Raghib A; Granström T; Eriksson JW; Lindholm Olinder A; Leksell J
Acta Ophthalmol; 2020 Jun; 98(4):360-367. PubMed ID: 31656056
[TBL] [Abstract][Full Text] [Related]
28. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
[TBL] [Abstract][Full Text] [Related]
29. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
[TBL] [Abstract][Full Text] [Related]
30. Prediction of anti-VEGF efficacy in diabetic macular oedema using intraocular cytokines and macular optical coherence tomography.
Mao J; Zhang S; Zheng Z; Deng X; Liu C; Chen Y; Zhao S; Zhang Y; Shen L
Acta Ophthalmol; 2022 Jun; 100(4):e891-e898. PubMed ID: 34403203
[TBL] [Abstract][Full Text] [Related]
31. Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema.
Rana V; Agarwal A; Arora A; Bansal R; Dogra M; Bhadada SK; Singh N; Gupta V
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S16-S21. PubMed ID: 38131536
[TBL] [Abstract][Full Text] [Related]
32. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
33. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
34. Sequential restoration of external limiting membrane and ellipsoid zone after intravitreal anti-VEGF therapy in diabetic macular oedema.
De S; Saxena S; Kaur A; Mahdi AA; Misra A; Singh M; Meyer CH; Akduman L
Eye (Lond); 2021 May; 35(5):1490-1495. PubMed ID: 32690922
[TBL] [Abstract][Full Text] [Related]
35. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography].
Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665
[TBL] [Abstract][Full Text] [Related]
36. Association of Disorganization of Retinal Inner Layers With Visual Acuity In Eyes With Uveitic Cystoid Macular Edema.
Grewal DS; O'Sullivan ML; Kron M; Jaffe GJ
Am J Ophthalmol; 2017 May; 177():116-125. PubMed ID: 28237411
[TBL] [Abstract][Full Text] [Related]
37. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
[TBL] [Abstract][Full Text] [Related]
38. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
Tang F; Qin X; Lu J; Song P; Li M; Ma X
Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
[TBL] [Abstract][Full Text] [Related]
39. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
[TBL] [Abstract][Full Text] [Related]
40. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
